Futurenest, recognized for AI governance and infrastructure, joins the inaugural cohort of the “TAI1 AI Accelerator”, launched by StarFab in collaboration with key local and global industry leaders and leveraging resources from the NVIDIA Inception… Read More »Futurenest Joins the Inaugural Cohort of TAI1 AI Accelerator, Showcases Its Flagship Product Xparse at GTC 2026
LONDON, April 15, 2026 /PRNewswire/ — Aryza, a global provider of E2E AI-enabled automation software across the credit & debt lifecycle, has acquired Umbrella Tech, a Toronto based leader in voice-based agentic AI for… Read More »Aryza Acquires Umbrella Tech, advancing Collection Intelligence with voice-based Agentic AI for the global Collections & Recoveries industry
KYOTO, Japan, April 15, 2026 /PRNewswire/ — Nuvoton Technology Corporation Japan (hereinafter “NTCJ”) announced on April 15 that it will start mass production of a “high-power violet laser diode (402 nm, 4.5 W)” that… Read More »Nuvoton Releases Industry-leading-class High-power Violet Laser Diode (402 nm, 4.5 W) — 1.5 times Higher Output Than Its Conventional Product
HONG KONG, April 15, 2026 /PRNewswire/ — On April 13, the 2026 Hong Kong International Innovation and Technology Expo (InnoEX 2026), co-organized by the HKSAR Government and the Hong Kong Trade Development Council, grandly… Read More »Hi-Think Shines at InnoEX 2026 in Hong Kong – Empowering Digital Intelligence with AI
Triple Board-Certified Physician, Entrepreneur, and Community Leader to Explore the Science Behind Skin Health, Confidence, and High Performance at BWBC 2026 Bakersfield, United States, April 15, 2026 — Dr. Shweta Agarwal of Youthology Medical Aesthetics… Read More »Dr. Shweta Agarwal to Present at Annual Bakersfield Women’s Business Conference
Creative Biolabs advances genetic medicine with reliable, high‑performance lipid nanoparticle solutions. United States, April 15, 2026 — Over the past decade, lipid nanoparticles (LNPs) have quietly evolved from a niche formulation tool into one of the… Read More »Creative Biolabs Announces Enhanced LNP Platform to Advance Next‑Generation Genetic Medicine